The Aleksandrovska University Hospital is a university hospital in Sofia, the capital of Bulgaria. It was founded in 1879 and was named after the Bulgarian Prince Alexander I Battenberg in October 1884. A military hospital between 1912 and 1919, it was the site where the Sofia Medical University was founded in 1917.

There are 1,100 beds in UMHAT 'Aleksandrovska' EAD.

During the past decade, UMHAT 'Aleksandrovska' EAD conducted 4 clinical trials. In the 10-year time frame, 4 clinical trials started and 6 clinical trials were completed, i.e. on average, 150% percent of trials that started reached the finish line to date. In the past 5 years, 2 clinical trials started and 2 clinical trials were completed. i.e. 100% of trials that started reached the finish line.

Out of the total clinical trials conducted in "UMHAT 'Aleksandrovska' EAD" #1 sponsor was "Janssen Research & Development, LLC" with 3 trials, followed by "Pfizer" with 2 trials sponsored, "Pfizer's Upjohn has merged with Mylan to form Viatris Inc." with 2 trials sponsored, "Bial - Portela C S.A." with 1 trials sponsored and "Rigel Pharmaceuticals" with 1 trials sponsored. Other sponsors include -5 different institutions and companies that sponsored additional 5 trials in total.

According to Clinical.Site data, the most researched conditions in "UMHAT 'Aleksandrovska' EAD" are "Psoriasis" (2 trials), "Crohn's Disease" (1 trials), "Epilepsy" (1 trials), "Generalized Tonic Clonic Seizures" (1 trials) and "Immune Thrombocytopenic Purpura" (1 trials). Many other conditions were trialed in "UMHAT 'Aleksandrovska' EAD" in a lesser frequency.

Most popular intervention types in "UMHAT 'Aleksandrovska' EAD" are "Drug" (9 trials), "Biological" (2 trials) and "Other" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (5 trials), "CP 690,550 10 mg" (1 trials), "CP 690,550 5 mg" (1 trials), "CP-690,550" (1 trials) and "Eslicarbazepine Acetate" (1 trials). Other intervention names were less common.

The vast majority of trials in "UMHAT 'Aleksandrovska' EAD" are 9 trials for "All" genders.

Currently, there are NaN active trials in "UMHAT 'Aleksandrovska' EAD". undefined are not yet recruiting, 1 are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 6 completed trials in UMHAT 'Aleksandrovska' EAD, undefined suspended trials, and 2 terminated clinical trials to date.

Out of the total trials that were conducted in UMHAT 'Aleksandrovska' EAD, 0 "Phase 1" clinical trials were conducted, 2 "Phase 2" clinical trials and 7 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".